Recombinant Botulinum Toxin Type A (YHNB)

重组A型肉毒毒素（耀海诺信生物）

Report date: 2025/05/21 14:53:25

Base Information

Drug NameRecombinant Botulinum Toxin Type A (YHNB)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > ToxinNatural product/Extract > Microbial extract
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTaizhou Ruihai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaizhou Ruihai Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A